URGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
UroGen Pharma Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$34.15−0.41 (-1.19%)
Close on Oct 19, 2026
- Market cap
- $1.72B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of UroGen Pharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 18, 2026 | Aug 20, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 22, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Apr 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2026 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Mar 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 26, 2025 | Aug 27, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 11, 2025 | Jul 15, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jul 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 30, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 14, 2025 | Feb 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2025 | Jan 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2024 | Oct 9, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2024 | Sep 24, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 12, 2024 | Sep 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 7, 2024 | Jul 1, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2024 | Jun 18, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 13, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 13, 2024 | SEC EDGAR |